FDA Updates Warnings on All Stimulants for ADHD, Other Conditions

May 15, 2023

(MedPage Today) – The FDA is updating warnings for stimulants prescribed for attention-deficit/hyperactivity disorder (ADHD) and other conditions, citing concerns about nonmedical use of the drugs. In a drug safety communication on Thursday, the agency said the boxed warning for the entire class of central nervous system stimulants would get standardized language to more clearly state the dangers — including the risk for misuse, abuse, addiction, overdose, and death — given that most of the current warnings are out of date. This class of drugs includes amphetamines such as Adderall and methylphenidate such as Ritalin and Concerta. (Read More)